רקוויפ מודוטאב 2 מג ישראל - עברית - Ministry of Health

רקוויפ מודוטאב 2 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 2 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקוויפ מודוטאב 8 מג ישראל - עברית - Ministry of Health

רקוויפ מודוטאב 8 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 8 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקוויפ מודוטאב 4 מג ישראל - עברית - Ministry of Health

רקוויפ מודוטאב 4 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 4 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רופינירול טבע   0.25 מג ישראל - עברית - Ministry of Health

רופינירול טבע 0.25 מג

teva pharmaceutical industries ltd, israel - ropinirole as hydrochloride - טבליות מצופות פילם - ropinirole as hydrochloride 0.25 mg - ropinirole - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

רופינירול טבע  2 מג ישראל - עברית - Ministry of Health

רופינירול טבע 2 מג

teva pharmaceutical industries ltd, israel - ropinirole as hydrochloride - טבליות מצופות פילם - ropinirole as hydrochloride 2 mg - ropinirole - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

רקויפ מודוטאב 2 מ"ג ישראל - עברית - Ministry of Health

רקויפ מודוטאב 2 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 2 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקויפ מודוטאב 8 מ"ג ישראל - עברית - Ministry of Health

רקויפ מודוטאב 8 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 8 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקויפ מודוטאב 4 מ"ג ישראל - עברית - Ministry of Health

רקויפ מודוטאב 4 מ"ג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 4 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רופינירול טבע ® 0.5 מ"ג ישראל - עברית - Ministry of Health

רופינירול טבע ® 0.5 מ"ג

teva pharmaceutical indust.ltd - ropinirole as hydrochloride 0.5 mg - film coated tablets - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

רופינירול טבע ® 1 מ"ג ישראל - עברית - Ministry of Health

רופינירול טבע ® 1 מ"ג

teva pharmaceutical indust.ltd - ropinirole as hydrochloride 1 mg - film coated tablets - ropinirole - treatment of idiopathic parkinson's disease: ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control "on-off" fluctuations and permit a reduction in the total daily dose of levodopa.